Tag: pharmaceuticals

Market Assessment

Pharma 2020: Key Pharma Industry Trends to Watch Out For

The pharma industry is undergoing a myriad of changes. Therefore, success in today’s pharmaceutical marketplace largely depends on companies’ ability to continually reassess strategic direction, move with agility, and anticipate and adapt to changes. Businesses must not only keep a close watch on the pharma industry trends, but equal emphasis should be given to tackling the upcoming challenges. Some of the key challenges identified during our pharma industry analysis include:

  • Increasing instances of chronic diseases are placing greater pressure on the healthcare budgets
  • Healthcare policy makers are increasing pressure on doctors regarding what to prescribe
  • Growing demand for medicines in emerging economies
  • Regulators are becoming increasingly cautious while approving new and innovative medicines
  • Pharma-economic performance is measured in order to insist on outcome-based pricing

How to overcome these challenges?

All you need a market intelligence solutions provider to guide you with the right solutions for business. Request a free brochure to gain insights into Infiniti’s advanced solutions for the pharma industry.

Pharma industry trends

Despite these challenges, there are several exciting pharma industry trends underway. Infiniti Research’s pharma industry analysis reveals the following trends that companies in this sector must gear up for:

Prevention over treatment

 One of the key pharma industry trends that are expected to go mainstream is the idea of prevention over treatment. Governments across the globe are backing this, especially in the case of chronic diseases. Global pharmaceutical industry analysis suggests that there is an unprecedented amount of supply in prevention supplements and pills around the world. If certain chronic diseases cannot be treated, some of its symptoms and fatal consequences can be prevented through such initiatives.

Reverse innovation

Reverse innovation refers to any innovation which is adopted first by emerging economies and then distributed globally. Pharma industry trends of the future such as reverse innovation provide answers to various challenges faced by companies in the pharma industry including the rising research costs, patent expiration, and consequent revenue declines, and huge costs in bringing a drug to market.

Nanotechnology

Nanotechnology is one of the most notable recent trends in the pharmaceutical industry. Nanotechnology is a scientific, multi-disciplinary effort that involves the creation and utilization of essence systems on a nanometer scale. An important application of this innovation is in the form of ‘Nano-medicine’. Pharma industry experts at Infiniti Research believe nanotechnology to be one of the most impressive pharma industry trends and will unleash several breakthroughs in medicine, diagnosis, and genetic engineering. A key example of an innovative nanomedicine is that of Genexol-PM which is an anti-cancer drug used to fight breast cancer and non-small lung cancer.

Customization or personalized medicine

People around the globe are known to have genetic differences, however, all of us consume similar medicine that has been designed for millions of people. However, this trend is about to change in the near future. Personalized medicine is expected to become one of the most favored pharma industry trends in the future. The drugs will be customized based on the patient’s examination reports and medical records. Though it would take some time for this to become full-fledged in the pharma industry, such trends in the pharma industry will provide enhanced treatment to the patients.  

How can Infiniti’s trend analysis solutions help companies in the pharma industry to keep a close watch on the recent market trends and revamp their strategies to stay at par with top players in the market? Request a proposal to find out.

3D printing

3D printers are under rapid development. The adaptation of this technology in the pharma industry will enable companies in the sector to print the necessary medicines as per requirements. In 2015, the first FDA approved a drug called Spritam was printed. This drug is used to treat epilepsy. This pill was made 3D printing several layers of the powdered drug, binding the layers of powder together, and blowing away the excess powder. The drug easily dissolves when compared to a traditional pill due to its unique structure. This is especially useful for cases where otherwise large, hard-to-swallow pills are prescribed.

Body sensors

Body sensors are breakthrough pharma industry trends that are all set to revamp patient-care and drug prescription. Wearables, integrated body chip, mini robots, and several other types of body sensors can obtain patient information and communicate the same immediately to the healthcare professionals. This can help them make quick and informed decisions regarding the drugs that need to be prescribed to the patient. These systems integrate living human cells with micro-engineering to help researchers and product development teams a new standard for predicting human response with greater precision.

Artificial intelligence

Artificial intelligence and cognitive computers help gather and classify large volumes of data in a matter of seconds. This solves the common problem that the drug discovery process is lengthy and expensive. These advanced technologies will also help pharma companies to run cognitive trials in lesser time. Which means drugs can be delivered to patients much earlier than before.

GET MORE INFO to know more about Infiniti’s solutions for business

semiconductor industry

Steps in Competitor Analysis of Pharma Companies

It is no new knowledge that the present scenario in the pharmaceutical industry is highly competitive.In the recent years, the pharma market has become even more competitive due to the availability of branded and generic product segments. Despite evidence to the contrary, several pharmaceutical companies perceive their competitive world as a relatively flat landscape. Consequently, numerous pharma companies and professionals still resort to outdated and superficial competitor analysis that limit their perceptions to competitors’ product and corporate profiles, particularly promotional spending and sales force allocations. These simplistic, often short-sighted approaches place pharma companies at risk from competitive threats and dangerous blind spots. As the pharmaceutical industry transitions to a shorter and less profitable life cycle model, competitive planning for brands and companies have become critical for growth. The foundation of this planning is competitor analysis, which is essentially the process of assessing and understanding the competitors to help design winning strategies and tactics. The drug development process is not only a process to formulate the most successful product or treatment for a particular condition, but also to research the market and successfully identify the competitors. Other key benefits of undertaking competitor analysis include targeting the right customers, market potential forecasting, and matching the competitor pricing. Here are some of the steps involved in conducting competitor analysis:Request Free Proposal

Finding the right team

The first step involved in conducting a  systematic, insightful and multidimensional competitor analysis is to find the right team. For any analysis, it’s imperative to have the ideal frameworks, processes, and tools. This could include a multidisciplinary team of internal consultants and external professionals if required. Firms should not solely depend on competitive intelligence dealers, who mainly focus on accumulation of data and competitive surveillance. Instead, they should use people with expertise in elaborate competitive analysis, planning, strategy, and implementation. With the help of these professionals. Companies can gain access to proper methodologies, tools, and structures to lead and assist the development of a competitive analysis process.

Competitive Personality Analysis

Many pharma companies make the mistake of assuming that their company is not a part of the competitive mix. However, corporate self-analysis is an indispensable part of the competitor analysis. Every company has its own distinct personality, and competitive personality analysis involves unearthing the personality of a company. It addresses critical questions like how a company thinks and acts, what is the competitor’s product profile, what salesforce will be used to back the competitor’s product, what will be the competitive differentiation, etc. Based on corporate presentations, executive profiles, competitive intelligence, and other information gathered by addressing such questions, pharma companies can penetrate into a competitor’ head and decipher their way of thinking and also their future course of action. 

Strategic stakeholder analysis

In today’s market, when physicians prescribe a particular drug and patients want that drug, sometimes they end up buying a different brand. Prescription power is now being transferred from patients and physical care providers to other strategic stakeholders. These stakeholders include regulators, governments, professional societies, policymakers, the media, health technology evaluation groups, retailers, etc. As stakeholders play an essential role in the adoption and use of particular brands, a detailed analysis of strategic stakeholders should be a critical aspect of every competitor analysis.

SWOT analysis

A SWOT analysis helps to identify and evaluate the strengths, weaknesses, opportunities, and threats that a company faces. The information gained is used to analyze the position of a company as well as that of their competitors. A SWOT analysis informs the upper management what the industry is outshining in, the improvements required, exploiting growth opportunities if possible and the preemptive measures that need to be taken to safeguard a company or shareholder value.


To know more about competitor analysis for pharma companies

Ask an analyst


Related Posts